Interleukin-10 gene polymorphisms influence susceptibility to cachexia in patients with low-third gastric cancer in a chinese population

Molecular Diagnosis and Therapy

Volumn 14, Issue 2, 2010, Pages 95-100

  Sun, Fengbo ^a   Sun, Yunbo ^a   Yu, Zhaohua ^a   Zhang, Dianliang ^a   Zhang, Jian ^a   Song, Bo ^b   Zheng, Hongmei ^a  

^a QINGDAO UNIVERSITY   (China)

^b YANTAISHAN HOSPITAL   (China)

Author keywords

Cachexia; Clinical genetics; Gastric cancer; Genotyping

Indexed keywords

INTERLEUKIN 10;

ADULT; ARTICLE; CACHEXIA; CHINESE; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

ASIAN CONTINENTAL ANCESTRY GROUP; CACHEXIA; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS;

EID: 77950521912     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.2165/11534360-000000000-00000     Document Type: Article

References (22)

1. Tan BH, Deans DA, Skipworth RJ, et al. Biomarkers for cancer cachexia: is there also a genetic component to cachexia? Support Care Cancer 2008; 16: 229-234
2. Dianliang Z. Probing cancer cachexia-anorexia: recent results with knockout, transgene and polymorphisms. Curr Opin Clin Nutr Metab Care 2009 May; 12 (3): 227-231
3. Inui A. Cancer cachexia-anorexia syndrome: current issues in research and management. CA Cancer J Clin 2002; 52: 72-91 (Pubitemid 34256834)
4. Ryan JL, Carroll JK, Ryan EP, et al. Mechanisms of cancer-related fatigue. Oncologist 2007; 12: 22-34
5. Pirlich M, Norman K, LochsH, et al. Role of intestinal function in cancer. Curr Opin Clin Nutr Metab Care 2006; 9: 603-606
6. Argiles JM, Busquets S, Garcia-Martonez C, et al. Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future. Nutrition 2005; 21: 977-985 (Pubitemid 41188098)
7. Zheng YB. Cancer cachexia and cytokines. J Int Oncol 2006 January; 33 (1): 29-32
8. Shibata M, Nezu T, Takekawa M, et al. Serum levels of interleukin-10 and interleukin-12 in patients with colorectal cancer. Ann N Y Acad Sci 1996 Oct 31; 795: 410-412 (Pubitemid 27029606)
9. Deans DA, Tan BH, Ross JA, et al. Cancer cachexia is associated with the IL10-1082 gene promoter polymorphism in patients with gastroesophageal malignancy. Am J Clin Nutr 2009; 89: 1164-1172
10. Mocellin S, Marincola FM, Young HA. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol 2005; 78: 1043-1051 (Pubitemid 41572467)
11. Kingo K, Ratsep R, Koks S, et al. Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility. J Dermatol Sci 2005; 37: 111-113 (Pubitemid 40126829)
12. Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24 (1): 1-8 (Pubitemid 27050850)
13. Fearon KC, Voss AC, Hustead DS, Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006 Jun; 83 (6): 1345-1350
14. UICC 2002. Sobin LH, Wittekind CH. TNM classification of malignant tumors. 6th ed. New York: Wiley-Liss, 2002: 52-56
15. Costa GC, da Costa Rocha MO, Moreira PR, et al. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis 2009 Feb 1; 199 (3): 451-454
16. Edwards-Smith CJ, Jonsson JR, Purdie DM, et al. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 1999 Aug; 30 (2): 526-530
17. Biostatistics and Bioinformatics Unit, Catalan Institute of Oncology. SNPStats: your web tool for SNP analysis [online]. Available from URL: http://bioinfo.iconcologia.net/index.php?module=Snpstats [Accessed 2010 Mar 9]
18. Poli F, Nocco A, Berra S, et al. Allele frequencies of polymorphisms of TNFa, IL-6, IL-10 and IFNG in an Italian Caucasian population. Eur J Immunogenet 2002; 29 (3): 237-240 (Pubitemid 34621798)
19. Perrey C, Pravica V, Sinnort PJ, et al. Genotyping for polmorphisms in interferon-g, interleukin-10, transforming growth factor-b1 and tumour necrosis factor-a gene: a technical report. Transpl Immunol 1998; 6 (3): 193-197 (Pubitemid 28521633)
20. Du R, Pan SY, Lu BX. Allele frequencies of polymorphisms of interleukin-10 promoter in Chinese Han population. Chinese Journal of Anatomy 2006; 29 (6): 686-689
21. Moraes MO, Santos AR, Schonkeren JJ, et al. Interleukin-10 promoter haplotypes are differently distributed in the Brazilian versus the Dutch population. Immunogenetics 2003; 54: 896-899
22. Wu MS, Wu CY, Chen CJ, et al. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int JCancer 2003; 104: 617-623